Focus Session
Organized by Evotec
iPSCs can serve as starting material for generating potentially limitless amounts of cells for therapeutic applications, especially when focusing on allogenic, off-the-shelf approaches in regenerative and anti-tumor medicine. This session emphasizes distinct strategies for different categories of therapeutic cells, such as mature cells derived from organoids, cell clusters, and single-cell populations. Predictive and efficient functional assays both for cellular maturation and immune-evasion are essential to determine the chances of product success.